Research Interests:
Primary: Industrial organization, competition economics, economics of health
Secondary: Development economics
Peer-reviewed Publications
Wattal, V. (2025) Competitive entry in the market for branded generic drugs , Journal of Economics and Management Strategy, 34.4 (2025): 1018-1037Â
Bullen, H., Wattal, V., Meacock R., Sutton, M. (2025) Determinants of quality in the independent and public hospital sectors in England , International Journal for Quality in Health Care, 37(1) (2025), mzaf019
Wattal, V., Checkland, K., Sutton, M., Morciano, M. (2024) What remains after the money ends? Evidence on whether admissions reductions continued following the largest health and social care integration programme in England, The European Journal of Health Economics, 25(9), 1485-1504
Fletcher, S., Eddama, O., Anderson, M., Meacock, R., Wattal, V. , Allen, P., Peckham, S. (2024). The impact of NHS outsourcing of elective care to the independent sector on outcomes for patients, healthcare professionals and the United Kingdom health care system: a rapid narrative review of literature, Health Policy, 150, 105166
Working papers
Peer effects of health education on development of chronic conditions- Evidence from a national diabetes prevention programme (with Rachel Meacock and Matt Sutton) (Under review)
Too big to fail, too few to choose? Corporates, market concentration and quality in England's specialised care sector (with Yiu-Shing Lau and Marcello Morciano) (Under review)
How to measure the effectiveness of healthcare providers acting as an `anchor institution': A case study of the NHS in Greater Manchester, England. (with Christine Camacho, Anna Gkiouleka, John Ford, Luke Munford) (Under review)
Price of new pharmaceuticals and price regulation in India, Centre for Competition Policy Working Paper (here)
Other ongoing research
Access to New Pharmaceuticals in India